- |
- |
- |
- |
- |
- |
Download Conference Programmme
Reading Room
Download PDFs of articles about influenza published in The Lancet journals
| 7:00-16.30 | Registration |
| 7:00- | Registration |
| 9:00-9:30 | Welcome and opening remarks |
| 9:30-10:30 | Session I: Overview—where are we with pandemic influenza? |
| Global status of human infection with H1N1 virus and influenza pandemic preparedness | |
| Regional situation update and pandemic response strategies | |
| Overview of pandemic H1N1 virology | |
| Overview of clinical characteristics of pandemic H1N1 infection | |
| 10:30-10:40 | Coffee break |
| Session II: Lesson learnt and challenges ahead | |
| 10:40-11:40 | Experience sharing and response strategy for the coming winter |
| 11:40-12:25 | Panel discussion |
| 12:30-14:00 | Lunch break |
| Session III: Latest scientific insights into the influenza virus | |
| 14:00-14:50 |
Update on H5N1 virology
Immune response to pandemic A/H1N1 virus by seasonal influenza vaccination Antiviral resistance monitoring Virological and serological study of the pandemic H1N1 influenza virus in mainland China |
| 14:50-15:20 | Q&A |
| 15:20-15:30 | Tea break |
| Session IV: Pandemic surveillance | |
| 15:30-17:00 |
1) WHO
2) Epidemiological findings of cases of 2009 influenza A (H1N1) virus infection in mainland China 3) Japan 4) US CDC 5) European CDC 6) Australia |
| 17:00-17:40 | Panel discussion |
| 18:30-21:00 | Welcome Reception |
| 7:00- | Registration |
| 8:30-8:40 | Opening |
| 8:40-10:30 | Session V: Clinical management |
| Overview and update on antiviral therapy and prophylaxis | |
| Clinical features of swine-origin influenza A (H1N1) | |
| Report on treatment of influenza A (H1N1) with traditional Chinese medicine | |
| Management of critically ill patients with pandemic H1N1 | |
| Pathogenesis and clinical observations of human infection with H5N1 and pandemic H1N1, 2009 | |
| 10:00-10:30 | Panel discussion |
| 10:30-10:40 | Coffee break |
| 10:40-12:30 | Session VI: Vaccine development |
| WHO global strategy on pandemic vaccine development | |
| Overview of influenza vaccine strain selection and seeds development | |
| Global overview of influenza vaccine manufacture | |
| Progress of the clinical trial of A (H1N1) influenza vaccine in China | |
| 12:10-12:30 | Panel discussion |
| 12:30-13:00 | Summary of the meeting and closing remarks by China Ministry of Health |
| 13:00-14:30 | Lunch Symposium |
| Session I: Strategic preparedness in the Asia-Pacific region | |
| 14:30-14:55 | Pandemic preparedness and H1N1 pandemic severity assessment in southeast Asia |
| 14:55-15:20 | How modeling can help us prepare for an influenza pandemic |
| 15:20-15:40 | Q&A |
| 15:40-16:00 | Tea break |
| Session II: Public health strategy and operation | |
| 16:00-16:25 | Implications for medical care of an influenza pandemic |
| 16:25-16:50 | Non-pharmaceutical public health interventions for pandemic influenza |
| 16:50-17:10 | Q&A |
| 7:00- | Registration |
| 8:15-9:00 | Breakfast Symposium |
| Session III: From strategy to operation: experience with influenza in the Asia-Pacific region | |
| 9:00-9:25 | Keynote speech: Pandemic influenza preparedness in the APAC region: from strategy to operation |
| 9:25-9:35 | Q&A |
| 9:35-10:10 | 1) China |
| 10:00-10:25 | 2) Vietnam |
| 10:25-10:50 | Coffee break |
| 10:50-12:50 |
3) Hong Kong, China
4) Thailand 5) Singapore 6) Taiwan, China 7) Australia/New Zealand 8) Pakistan |
| 12:50-13:15 | Q&A |
| 13:15-14:30 | Lunch Symposium |
| Session IV: Seasonal influenza | |
| 14:30-14:55 | The evolution of seasonal influenza strains |
| 14:55-15:20 | Reducing the disease burden of influenza in children and adults |
| 15:20-15:40 | Tea break |
| 15:40-16:05 | The value of vaccinating the elderly |
| 16:05-16:30 | Seasonal flu control and its implication for pandemic preparedness |
| 16:30-16:55 | Q&A |
| 16:55-17:00 | Concluding Remarks |